GlassScriptPhysician profile
Rashi Prakash
NPI 1124583190
$2,602.41
in general payments reported to CMS, 2019-2025
11 companies · $1,844 in 2025
The $1,844 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $19.40 · 2021: $218 · 2022: $153 · 2023: $56.99 · 2024: $79.60 · 2025: $1,844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,194 · Travel and Lodging: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,194.43 |
| Travel and Lodging | $786.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,467.80 | 2024-2025 | |
| Glaukos Corporation | $256.10 | 2022-2025 | Idosetr |
| Novartis Pharmaceuticals Corporation | $237.31 | 2021-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $231.01 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $158.90 | 2024-2025 | |
| Optos, INC. | $93.75 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $58.91 | 2025 | Xdemvy |
| Alcon Vision LLC | $50.74 | 2023-2025 | Total30, Precision7 |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Rxsight INC | $14.65 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Coopervision INC. | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rashi Prakash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.